Vetting a Contract Manufacturing Partner for Your Clinical Diagnostics Kit

Expertise in scaling from assay development through manufacturing

Vetting potential CMO partners is as critical as developing your product, and success is dependent on multiple factors. Significantly, your partner’s capabilities must align with your needs. Demonstrated expertise with your technology, assay, and format is essential. If your project is early stage, bringing it to market may require significant assistance. An assay that works reliably on the bench top often requires further assay development and reagent reformulations when moved to scale- up. For products early in development, finding a CMO partner who not only has expertise with the technology but also the resources to assist with product and assay development can accelerate the time to market significantly. A partner with experience in your assay format can guide you on choosing fit-for-use materials that are aligned with regulatory requirements and supply-chain secure, both of which can save significant time and cost by minimizing the likelihood of costly reworks.

Successful assay commercialization in shifting regulatory environments

Changes in international standards and regulations have created challenges and roadblocks to the commercialization of diagnostic kits. The choice of a CMO partner with the expertise to provide guidance and manufacturing capabilities is one strategy clinical diagnostics companies can use to mitigate risk. A well-chosen CMO partner can accelerate the commercialization process by anticipating potential roadblocks.

Globally, changes to the regulatory environment need to be considered when choosing a contract manufacturing partner. In Europe, the transition from IVDD to IVDR has altered the commercialization calculus. Previously, the regulatory hurdles were lower in Europe and many companies would launch a CE-marked kit while waiting on FDA approvals. Under IVDR, it is expected that over 90% of IVDs (up from 10%) will require notified body involvement. If the decision is made to obtain a CE mark, is your CMO partner willing and/or able to be compliant with IVDR? This includes being willing to host unannounced audits by notified bodies as required by the new regulations.

Robust Quality Management System (QMS), document control, and audit response

Beyond the proper certifications, a potential CM partner should also be willing and able to demonstrate a robust QMS and that they have processes and controls in place for documentation. Can they provide you with records of successful audits? Can they guide and assist you with your regulatory submission? Additionally, you should verify that they have experience with preparing a Design History File (DHF), Device History Record (DHR) and Device Master Record (DMR).

While the commercialization pathway for IVD devices is complicated, a knowledgeable contract manufacturing partner can save significant time, money, and aggravation by providing design, quality, and regulatory assistance. Chosen wisely, a CMO partner can smooth roadblocks, navigate regulatory hurdles, and speed time to market.

To learn more about our Contract Manufacturing Capabilities for the clinical diagnostics industry, or discuss your project with our assay development specialists, visit our IVD services page Diagnostic OEM & CMO Services.